Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 26.06
+0.56 (2.20%)
At close: Mar 6, 2026
Wuhan Hvsen Biotechnology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 1,606 | 1,139 | 966.95 | 934.11 | 964.74 | 739.79 | Upgrade
|
| Other Revenue | 61.09 | 61.09 | 52.81 | 88.79 | 31.48 | 37.67 | Upgrade
|
| Revenue | 1,667 | 1,200 | 1,020 | 1,023 | 996.22 | 777.46 | Upgrade
|
| Revenue Growth (YoY) | 48.74% | 17.71% | -0.31% | 2.68% | 28.14% | 81.98% | Upgrade
|
| Cost of Revenue | 1,233 | 1,006 | 809.11 | 800.16 | 727.71 | 491.59 | Upgrade
|
| Gross Profit | 434.22 | 194.72 | 210.65 | 222.75 | 268.51 | 285.87 | Upgrade
|
| Selling, General & Admin | 126.22 | 118.74 | 131.31 | 101.98 | 88.49 | 85.88 | Upgrade
|
| Research & Development | 70.87 | 55.8 | 44.6 | 40.14 | 46.89 | 28.38 | Upgrade
|
| Other Operating Expenses | -2.01 | 3.52 | 3.23 | 8.84 | 4.92 | 4.41 | Upgrade
|
| Operating Expenses | 201.57 | 176.37 | 204.08 | 161.73 | 133.23 | 123.43 | Upgrade
|
| Operating Income | 232.65 | 18.35 | 6.57 | 61.01 | 135.28 | 162.43 | Upgrade
|
| Interest Expense | -20.6 | -42.66 | -28.22 | -18.38 | -2.87 | -2.3 | Upgrade
|
| Interest & Investment Income | 7.75 | 10.03 | 17.47 | 10.31 | 10.54 | 6.75 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.69 | 0.69 | -0.16 | -0.03 | -0.03 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.14 | -1.35 | -0.62 | -0.67 | -0.47 | -0.38 | Upgrade
|
| EBT Excluding Unusual Items | 217.35 | -14.96 | -4.95 | 52.24 | 142.45 | 166.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | 20.19 | -23.64 | 12.25 | 1.46 | 1.55 | 0.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.01 | -0.06 | - | Upgrade
|
| Asset Writedown | -0.34 | - | - | - | - | -0.41 | Upgrade
|
| Other Unusual Items | 9.62 | 9.62 | 5.14 | 3 | 6.89 | 9.34 | Upgrade
|
| Pretax Income | 246.82 | -28.97 | 12.44 | 56.71 | 150.83 | 176.03 | Upgrade
|
| Income Tax Expense | 30.49 | -9.2 | -4.34 | 4 | 17.97 | 25.88 | Upgrade
|
| Earnings From Continuing Operations | 216.33 | -19.77 | 16.78 | 52.71 | 132.87 | 150.16 | Upgrade
|
| Minority Interest in Earnings | -0.92 | -0.38 | - | - | - | - | Upgrade
|
| Net Income | 215.41 | -20.16 | 16.78 | 52.71 | 132.87 | 150.16 | Upgrade
|
| Net Income to Common | 215.41 | -20.16 | 16.78 | 52.71 | 132.87 | 150.16 | Upgrade
|
| Net Income Growth | - | - | -68.16% | -60.33% | -11.52% | 118.36% | Upgrade
|
| Shares Outstanding (Basic) | 181 | 166 | 166 | 165 | 166 | 147 | Upgrade
|
| Shares Outstanding (Diluted) | 181 | 166 | 166 | 165 | 166 | 147 | Upgrade
|
| Shares Change (YoY) | 8.54% | -0.06% | 0.33% | -0.19% | 12.59% | 18.45% | Upgrade
|
| EPS (Basic) | 1.19 | -0.12 | 0.10 | 0.32 | 0.80 | 1.02 | Upgrade
|
| EPS (Diluted) | 1.19 | -0.12 | 0.10 | 0.32 | 0.80 | 1.02 | Upgrade
|
| EPS Growth | - | - | -68.27% | -60.25% | -21.41% | 84.35% | Upgrade
|
| Free Cash Flow | 121.46 | -150.89 | -91.39 | -332.18 | -444.4 | -182.49 | Upgrade
|
| Free Cash Flow Per Share | 0.67 | -0.91 | -0.55 | -2.01 | -2.68 | -1.24 | Upgrade
|
| Dividend Per Share | 0.206 | 0.106 | 0.270 | 0.300 | 0.331 | 0.273 | Upgrade
|
| Dividend Growth | -23.55% | -60.59% | -10.00% | -9.37% | 21.11% | - | Upgrade
|
| Gross Margin | 26.04% | 16.22% | 20.66% | 21.78% | 26.95% | 36.77% | Upgrade
|
| Operating Margin | 13.95% | 1.53% | 0.64% | 5.96% | 13.58% | 20.89% | Upgrade
|
| Profit Margin | 12.92% | -1.68% | 1.65% | 5.15% | 13.34% | 19.31% | Upgrade
|
| Free Cash Flow Margin | 7.29% | -12.57% | -8.96% | -32.48% | -44.61% | -23.47% | Upgrade
|
| EBITDA | 340.34 | 131.48 | 126.96 | 123.58 | 163.82 | 181.52 | Upgrade
|
| EBITDA Margin | 20.41% | 10.95% | 12.45% | 12.08% | 16.44% | 23.35% | Upgrade
|
| D&A For EBITDA | 107.69 | 113.13 | 120.39 | 62.57 | 28.54 | 19.08 | Upgrade
|
| EBIT | 232.65 | 18.35 | 6.57 | 61.01 | 135.28 | 162.43 | Upgrade
|
| EBIT Margin | 13.95% | 1.53% | 0.64% | 5.96% | 13.58% | 20.89% | Upgrade
|
| Effective Tax Rate | 12.35% | - | - | 7.06% | 11.91% | 14.70% | Upgrade
|
| Revenue as Reported | 1,667 | 1,200 | 1,020 | 2,046 | 996.22 | 777.46 | Upgrade
|
| Advertising Expenses | - | 6.83 | 6.78 | 3.2 | 1.71 | 3.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.